EDC4 anticorps (N-Term)
Aperçu rapide pour EDC4 anticorps (N-Term) (ABIN632803)
Antigène
Voir toutes EDC4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- EDC4 antibody was raised against the N terminal of EDC4
-
Purification
- Affinity purified
-
Immunogène
- EDC4 antibody was raised using the N terminal of EDC4 corresponding to a region with amino acids LQEKQVICLSGDDSSTCIGILAKEVEIVASSDSSISSKARGSNKVKIQPV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EDC4 Blocking Peptide, (ABIN5613301), is also available for use as a blocking control in assays to test for specificity of this EDC4 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EDC4 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EDC4 (Enhancer of mRNA Decapping 4 (EDC4))
-
Autre désignation
- EDC4
-
Sujet
- In the process of mRNA degradation, EDC4 seems to play a role in mRNA decapping. It is the component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. EDC4 promotes complex formation between DCP1A and DCP2.It enhances the catalytic activity of DCP2 (in vitro).
-
Poids moléculaire
- 152 kDa (MW of target protein)
Antigène
-